Literature DB >> 27330497

Locoregional Therapy for Patients With Hepatocellular Carcinoma.

Jean-Francois H Geschwind1.   

Abstract

Entities:  

Year:  2015        PMID： 27330497      PMCID： PMC4849522     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  Intraarterial therapies for primary liver cancer: state of the art.

Authors:  Julius Chapiro; Vania Tacher; Jean-François Geschwind
Journal:  Expert Rev Anticancer Ther       Date:  2013-10-07       Impact factor: 4.512

2.  Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results.

Authors:  David P Cosgrove; Diane K Reyes; Timothy M Pawlik; Allen L Feng; Ihab R Kamel; Jean-François H Geschwind
Journal:  Radiology       Date:  2015-06-11       Impact factor: 11.105

3.  Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Authors:  Timothy M Pawlik; Diane K Reyes; David Cosgrove; Ihab R Kamel; Nikhil Bhagat; Jean-Francois H Geschwind
Journal:  J Clin Oncol       Date:  2011-09-12       Impact factor: 44.544

Review 4.  Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.

Authors:  Ann Lii Cheng; Deepak Amarapurkar; Yee Chao; Pei-Jer Chen; Jean-François Geschwind; Khean L Goh; Kwang-Hyub Han; Masatoshi Kudo; Han Chu Lee; Rheun-Chuan Lee; Laurentius A Lesmana; Ho Yeong Lim; Seung Woon Paik; Ronnie T Poon; Chee-Kiat Tan; Tawesak Tanwandee; Gaojun Teng; Joong-Won Park
Journal:  Liver Int       Date:  2013-11-20       Impact factor: 5.828

5.  Science to Practice: The Changing Face of Local Tumor Therapies-Do We Have to Think Systemically When Treating Cancer Locally?

Authors:  Julius Chapiro; Jean-François Geschwind
Journal:  Radiology       Date:  2015-08       Impact factor: 11.105

Review 6.  Combination of intra-arterial therapies and sorafenib: is there a clinical benefit?

Authors:  Julius Chapiro; Rafael Duran; Jean-François Geschwind
Journal:  Radiol Med       Date:  2014-06-04       Impact factor: 3.469
  6 in total
  3 in total

Review 1.  LI-RADS 2017: An update.

Authors:  Ania Z Kielar; Victoria Chernyak; Mustafa R Bashir; Richard K Do; Kathryn J Fowler; Donald G Mitchell; Milena Cerny; Khaled M Elsayes; Cynthia Santillan; Aya Kamaya; Yuko Kono; Claude B Sirlin; An Tang
Journal:  J Magn Reson Imaging       Date:  2018-04-06       Impact factor: 4.813

2.  Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology.

Authors:  Yukai He; Fenghua Liu; Shaofeng Mou; Qingyan Li; Sikui Wang
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

Review 3.  Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity.

Authors:  Corinne E Wessner; Colette M Shaw; Maria Stanczak; Flemming Forsberg; Andrej Lyshchik; Allison Tan; John R Eisenbrey
Journal:  Ultrasound Q       Date:  2020-09       Impact factor: 1.462
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.